|
MechanismBacterial DNA gyrase inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1986 |
|
Mechanismβ-adrenoceptors antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date17 Aug 1978 |
|
MechanismCav1.2 antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date25 Jun 1965 |
100 Clinical Results associated with Central Pharmaceutical JSC No. 3
0 Patents (Medical) associated with Central Pharmaceutical JSC No. 3
100 Deals associated with Central Pharmaceutical JSC No. 3
100 Translational Medicine associated with Central Pharmaceutical JSC No. 3